We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » U.S. FDA Issues Final Guidance on PMA/PDP Pre-Sub Program
U.S. FDA Issues Final Guidance on PMA/PDP Pre-Sub Program
Devicemakers planning a premarket approval application or product development protocol should take advantage of presubmission meetings with the U.S. Food and Drug Administration to pin down exactly what data the agency expects to support safety and efficacy of a new product.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor